Marc Pourrier

Author PubWeight™ 12.62^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Differential distribution of cardiac ion channel expression as a basis for regional specialization in electrical function.	Circ Res	2002	2.00
2	Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations.	Heart Rhythm	2011	1.44
3	Barium block of Kir2 and human cardiac inward rectifier currents: evidence for subunit-heteromeric contribution to native currents.	Cardiovasc Res	2003	1.12
4	KvLQT1 modulates the distribution and biophysical properties of HERG. A novel alpha-subunit interaction between delayed rectifier currents.	J Biol Chem	2003	1.11
5	Kir2.4 and Kir2.1 K(+) channel subunits co-assemble: a potential new contributor to inward rectifier current heterogeneity.	J Physiol	2002	0.98
6	Comparison of ion channel distribution and expression in cardiomyocytes of canine pulmonary veins versus left atrium.	Cardiovasc Res	2005	0.96
7	The new antiarrhythmic drug vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillation.	Cardiovasc Res	2013	0.93
8	The molecular basis of high-affinity binding of the antiarrhythmic compound vernakalant (RSD1235) to Kv1.5 channels.	Mol Pharmacol	2007	0.89
9	Rate-dependent effects of vernakalant in the isolated non-remodeled canine left atria are primarily due to block of the sodium channel: comparison with ranolazine and dl-sotalol.	Circ Arrhythm Electrophysiol	2012	0.88
10	Effects of flecainide and quinidine on Kv4.2 currents: voltage dependence and role of S6 valines.	Br J Pharmacol	2003	0.88
11	Atrial selective effects of intravenously administered vernakalant in conscious beagle dogs.	J Cardiovasc Pharmacol	2011	0.80
12	Ranolazine improves diastolic function in spontaneously hypertensive rats.	Am J Physiol Heart Circ Physiol	2014	0.78
13	The interaction between delayed rectifier channel alpha-subunits does not involve hetero-tetramer formation.	Naunyn Schmiedebergs Arch Pharmacol	2015	0.75
14	Comparison of the in vivo hemodynamic effects of the antiarrhythmic agents vernakalant and flecainide in a rat hindlimb perfusion model.	J Cardiovasc Pharmacol	2011	0.75